CN Stock MarketDetailed Quotes
688253 Innovita Biological Technology
- 41.07
- -0.03-0.07%
Post Market Oct 17 15:00 CST
5.60BMarket Cap18.51P/E (TTM)
42.12High40.95Low18.18KlotVolume41.40Open41.10Pre Close75.22MTurnover2.64%Turnover Ratio32.21P/E (Static)136.46MShares52.6952wk High2.80P/B2.83BFloat Cap18.7252wk Low49.32Limit Up68.81MShs Float52.69Historical High32.88Limit Down2.85%Amplitude18.72Historical Low0.40Dividend TTM41.38Avg Price9.16KlotAsk0.97%Div YieldTTM100Lot Size8.41KlotBid
Innovita Biological Technology Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 170.09%386.54M | 403.65%263.71M | 6.47%504.78M | -18.56%219.33M | -32.06%143.11M | -33.13%52.36M | 36.04%474.1M | -1.85%269.3M | -4.82%210.66M | -41.63%78.31M |
| Refunds of taxes and levies | -93.04%306.41K | -94.44%190.87K | 78.57%10.63M | -13.36%4.7M | 331.03%4.4M | 577.80%3.44M | -39.80%5.96M | -43.92%5.42M | -88.78%1.02M | -93.30%506.79K |
| Cash received relating to other operating activities | -62.29%10.73M | 22.17%7.39M | -8.24%22.59M | 69.62%31.72M | 104.82%28.46M | -53.76%6.05M | 31.70%24.62M | 368.79%18.7M | 311.63%13.89M | 483.49%13.08M |
| Cash inflows from operating activities | 125.93%397.58M | 338.67%271.29M | 6.60%538M | -12.84%255.75M | -21.99%175.97M | -32.70%61.84M | 33.84%504.67M | 1.87%293.43M | -3.52%225.57M | -36.17%91.89M |
| Goods services cash paid | 11.24%71.93M | 7.15%43.78M | -48.65%82.44M | -21.48%74.99M | -10.79%64.66M | 155.96%40.86M | 133.89%160.56M | 39.16%95.51M | 37.55%72.48M | -45.38%15.96M |
| Staff behalf paid | 32.01%52.6M | 29.59%31.14M | -5.72%76.03M | -6.79%56.04M | -7.89%39.85M | -28.34%24.03M | 7.25%80.65M | -2.35%60.12M | -8.39%43.26M | 3.96%33.54M |
| All taxes paid | 114.34%73.35M | 147.05%46.27M | 42.57%56.62M | 43.52%45.24M | 67.40%34.22M | 203.50%18.73M | -24.52%39.71M | -37.85%31.52M | -50.42%20.44M | -67.95%6.17M |
| Cash paid relating to other operating activities | 47.18%42.61M | 273.00%26.1M | -35.21%63.05M | -41.22%37.95M | -36.17%28.95M | -69.78%7M | 30.88%97.32M | 8.51%64.57M | 5.90%45.36M | -25.00%23.15M |
| Cash outflows from operating activities | 43.42%240.5M | 62.54%147.29M | -26.46%278.15M | -14.90%214.23M | -7.63%167.69M | 14.97%90.61M | 39.67%378.24M | 4.70%251.72M | -1.32%181.54M | -29.38%78.82M |
| Net cash flows from operating activities | 1,795.21%157.08M | 531.00%124M | 105.53%259.85M | -0.44%41.52M | -81.18%8.29M | -320.02%-28.77M | 18.97%126.43M | -12.41%41.71M | -11.62%44.03M | -59.60%13.08M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 38.74%2.42B | 4.47%1.15B | 68.50%3.17B | 125.22%2.54B | 645.69%1.75B | 1,895.94%1.1B | 145.23%1.88B | 115.40%1.13B | -37.17%234.1M | -79.36%55.05M |
| Cash received from returns on investments | 99.89%20.63M | 67.67%11.09M | 164.53%17.99M | 360.08%16.96M | 317.92%10.32M | 643.77%6.61M | 300.72%6.8M | 126.71%3.69M | 77.32%2.47M | 27.81%889.25K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --400 | --117.03K | --1.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --2.02M | --2.02M | ---- | ---- |
| Cash inflows from investing activities | 39.10%2.44B | 4.86%1.16B | 68.66%3.19B | 125.58%2.55B | 642.26%1.76B | 1,876.03%1.11B | 145.84%1.89B | 115.82%1.13B | -36.74%236.57M | -79.08%55.94M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 107.60%14.03M | 96.23%11.13M | -70.60%16.97M | -69.19%9.44M | -64.99%6.76M | -1.95%5.67M | -9.46%57.71M | -45.51%30.66M | -58.71%19.31M | -80.75%5.79M |
| Cash paid to acquire investments | 23.94%2.22B | 22.84%1.2B | 23.34%3.6B | 36.51%2.77B | 543.87%1.79B | 832.27%978.88M | 291.92%2.92B | 274.42%2.03B | -28.79%278.5M | -63.05%105M |
| Cash paid relating to other investing activities | --1M | --1M | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 24.31%2.24B | 23.37%1.21B | 21.56%3.62B | 34.94%2.77B | 504.39%1.8B | 788.69%984.55M | 268.17%2.98B | 244.29%2.06B | -31.98%297.81M | -64.74%110.79M |
| Net cash flows from investing activities | 566.60%205.1M | -145.96%-55.54M | 60.50%-428.92M | 76.07%-221.16M | 28.22%-43.96M | 320.29%120.82M | -2,665.14%-1.09B | -1,170.53%-924.35M | 4.10%-61.24M | -16.98%-54.85M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | --820.07M | --820.07M | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | --17.57M | --17.57M | --10M | --10M |
| Cash received relating to other financing activities | ---- | ---- | ---- | --25.56K | --25.56K | --25.56K | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | -100.00%25.56K | -99.74%25.56K | -99.74%25.56K | --837.64M | --837.64M | --10M | --10M |
| Borrowing repayment | ---- | ---- | --17.57M | --17.63M | --17.63M | --10M | ---- | ---- | ---- | ---- |
| Dividend interest payment | 120.66%53.83M | ---- | 10,316.63%22.64M | 14,016.55%24.39M | 19,079.27%24.39M | -64.14%23.13K | -99.57%217.38K | -99.65%172.81K | -99.74%127.19K | -2.28%64.49K |
| Cash payments relating to other financing activities | -14.35%1.86M | 5.16%1.05M | -80.31%4.26M | -73.00%3.1M | 117.00%2.17M | 256.76%1M | 1,714.50%21.64M | 1,249.53%11.48M | 70.77%999.16K | 1.05%280.3K |
| Cash outflows from financing activities | 26.01%55.69M | -90.46%1.05M | 103.48%44.48M | 287.10%45.13M | 3,823.66%44.19M | 3,096.98%11.02M | -63.29%21.86M | -80.31%11.66M | -98.03%1.13M | -96.00%344.8K |
| Net cash flows from financing activities | -26.08%-55.69M | 90.44%-1.05M | -105.45%-44.48M | -105.46%-45.1M | -597.75%-44.17M | -213.90%-11M | 1,470.01%815.78M | 1,495.14%825.98M | 115.52%8.87M | 211.87%9.66M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -69.26%655.86K | 104.09%146.66K | -96.87%1.33M | -95.56%2.05M | -90.59%2.13M | -95.07%-3.59M | 537.25%42.65M | 1,813.31%46.12M | 625.20%22.68M | -171.42%-1.84M |
| Net increase in cash and cash equivalents | 495.28%307.15M | -12.79%67.56M | -109.95%-212.21M | -2,013.73%-222.7M | -641.81%-77.7M | 328.15%77.47M | -4,286.34%-101.07M | 87.89%-10.54M | 118.99%14.34M | -65.01%-33.95M |
| Add:Begin period cash and cash equivalents | -56.04%166.46M | -56.04%166.46M | -21.07%378.67M | -21.07%378.67M | -21.07%378.67M | -21.07%378.67M | -0.48%479.74M | -0.48%479.74M | -0.48%479.74M | -0.48%479.74M |
| End period cash equivalent | 57.36%473.61M | -48.69%234.03M | -56.04%166.46M | -66.76%155.97M | -39.09%300.97M | 2.32%456.14M | -21.07%378.67M | 18.78%469.21M | 21.54%494.08M | -3.40%445.79M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- | -- |
| Auditor | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data